X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1051) 1051
index medicus (996) 996
male (630) 630
female (591) 591
orbital neoplasms - drug therapy (472) 472
ophthalmology (388) 388
middle aged (326) 326
adult (271) 271
orbital neoplasms - pathology (263) 263
tomography, x-ray computed (247) 247
aged (243) 243
magnetic resonance imaging (223) 223
child (201) 201
infant (195) 195
orbital neoplasms - diagnosis (195) 195
antineoplastic combined chemotherapy protocols - therapeutic use (192) 192
child, preschool (175) 175
diagnosis, differential (163) 163
oncology (152) 152
orbital neoplasms - radiotherapy (151) 151
treatment outcome (150) 150
surgery (137) 137
adolescent (133) 133
combined modality therapy (129) 129
antineoplastic agents - therapeutic use (124) 124
retrospective studies (120) 120
abridged index medicus (117) 117
tumors (114) 114
chemotherapy (113) 113
follow-up studies (112) 112
orbit (111) 111
biopsy (107) 107
orbital neoplasms - secondary (106) 106
orbital neoplasms - surgery (106) 106
cancer (102) 102
radiotherapy (102) 102
orbital neoplasms - diagnostic imaging (100) 100
pediatrics (91) 91
care and treatment (90) 90
orbital neoplasms - therapy (90) 90
prognosis (90) 90
diagnosis (89) 89
therapy (82) 82
orbital neoplasms - complications (81) 81
children (80) 80
aged, 80 and over (76) 76
exophthalmos - etiology (71) 71
orbital diseases - diagnosis (69) 69
eyelid neoplasms - drug therapy (63) 63
management (61) 61
eye diseases (58) 58
hematology (57) 57
medicine & public health (54) 54
orbit - pathology (52) 52
drug therapy, combination (50) 50
lymphomas (50) 50
prednisone - therapeutic use (50) 50
infant, newborn (49) 49
orbital diseases - drug therapy (49) 49
glucocorticoids - therapeutic use (48) 48
rhabdomyosarcoma - drug therapy (48) 48
administration, oral (47) 47
radiology, nuclear medicine & medical imaging (47) 47
drug therapy (45) 45
cyclophosphamide - administration & dosage (43) 43
eye (42) 42
rituximab (42) 42
vincristine - administration & dosage (42) 42
fatal outcome (41) 41
hemangioma, capillary - drug therapy (41) 41
metastasis (41) 41
neoplasm staging (41) 41
disease (40) 40
hemangioma - drug therapy (40) 40
patients (40) 40
visual acuity (40) 40
health aspects (39) 39
orbital neoplasms - mortality (39) 39
lymphoma (38) 38
remission induction (38) 38
eye neoplasms - drug therapy (37) 37
lymphoma, non-hodgkin - drug therapy (37) 37
cyclophosphamide - therapeutic use (36) 36
radiography (36) 36
animals (35) 35
diseases (35) 35
rhabdomyosarcoma - radiotherapy (35) 35
time factors (35) 35
b-cell lymphoma (34) 34
clinical neurology (34) 34
doxorubicin - administration & dosage (34) 34
eye neoplasms - pathology (34) 34
young adult (34) 34
case studies (33) 33
eyelid neoplasms - pathology (33) 33
head (33) 33
immunohistochemistry (33) 33
lymphoma, b-cell, marginal zone - drug therapy (33) 33
non-hodgkins-lymphoma (33) 33
radiotherapy dosage (33) 33
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1014) 1014
French (37) 37
German (32) 32
Japanese (15) 15
Spanish (13) 13
Portuguese (7) 7
Russian (6) 6
Chinese (5) 5
Polish (5) 5
Romanian (3) 3
Danish (2) 2
Hebrew (2) 2
Italian (2) 2
Arabic (1) 1
Czech (1) 1
Dutch (1) 1
Finnish (1) 1
Hungarian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology Biology Physics, ISSN 0360-3016, 06/2012, Volume 83, Issue 2, pp. 720 - 726
Purpose: To analyze the effect of reduced-dose radiotherapy on local control in children with low-risk rhabdomyosarcoma (RMS) treated in the Children's... 
Radiotherapy | Local control | Low risk | Rhabdomyosarcoma | PARAMENINGEAL RHABDOMYOSARCOMA | INTERNATIONAL SOCIETY | INTERGROUP-RHABDOMYOSARCOMA | NONMETASTATIC RHABDOMYOSARCOMA | SURGICAL-MANAGEMENT | FAILURE | RADIATION-THERAPY | STUDY-IV | GROUP-III PATIENTS | ONCOLOGY | PATIENT | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Lymph Node Excision | Prostatic Neoplasms - radiotherapy | Age Factors | Humans | Child, Preschool | Infant | Male | Rhabdomyosarcoma, Embryonal - surgery | Neoplasm, Residual | Young Adult | Rhabdomyosarcoma, Embryonal - secondary | Treatment Failure | Adult | Female | Urogenital Neoplasms - drug therapy | Orbital Neoplasms - surgery | Child | Infant, Newborn | Orbital Neoplasms - radiotherapy | Prostatic Neoplasms - drug therapy | Rhabdomyosarcoma, Embryonal - pathology | Quality Control | Prostatic Neoplasms - pathology | Drug Administration Schedule | Prostatic Neoplasms - surgery | Head and Neck Neoplasms - drug therapy | Orbital Neoplasms - pathology | Urogenital Neoplasms - pathology | Orbital Neoplasms - drug therapy | Lymphatic Metastasis | Rhabdomyosarcoma, Embryonal - drug therapy | Tumor Burden | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - radiotherapy | Radiotherapy Dosage - standards | Urogenital Neoplasms - radiotherapy | Adolescent | Combined Modality Therapy - methods | Urogenital Neoplasms - surgery | Rhabdomyosarcoma, Embryonal - radiotherapy | Second-Look Surgery | Head and Neck Neoplasms - surgery | Index Medicus | SURGERY | PATIENTS | NEOPLASMS | LYMPH NODES | FAILURES | RADIOLOGY AND NUCLEAR MEDICINE | ENDOXAN | RADIATION DOSES | RADIOTHERAPY | CHILDREN | CONTROL | HAZARDS
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 88, Issue 3, pp. 650 - 654
Purpose To evaluate the natural history, behavior of progression, prognostic factors, and treatment-related adverse effects of primary ocular adnexal... 
Radiology | Hematology, Oncology and Palliative Medicine | B-CELL LYMPHOMA | ONCOLOGY | PRIMARY ORBITAL LYMPHOMA | MARGINAL ZONE | INVOLVED-FIELD RADIOTHERAPY | NON-HODGKINS-LYMPHOMA | MALT LYMPHOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Cyclophosphamide - administration & dosage | Lymphoma, B-Cell, Marginal Zone - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Male | Lymphoma, B-Cell, Marginal Zone - mortality | Eye Neoplasms - drug therapy | Young Adult | Aged, 80 and over | Vincristine - administration & dosage | Adult | Female | Lymphoma, B-Cell, Marginal Zone - pathology | Retrospective Studies | Orbital Neoplasms - radiotherapy | Doxorubicin - administration & dosage | Radiotherapy Dosage | Prednisone - administration & dosage | Japan | Eye Neoplasms - pathology | Orbital Neoplasms - pathology | Rituximab | Orbital Neoplasms - drug therapy | Treatment Outcome | Disease Progression | Eye Neoplasms - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, B-Cell, Marginal Zone - drug therapy | Adolescent | Aged | Cataract - prevention & control | Orbital Neoplasms - mortality | Eye Neoplasms - radiotherapy | Antimitotic agents | Care and treatment | Nuclear radiation | Patient outcomes | Lymphomas | Radiotherapy | Antineoplastic agents | Cancer | Index Medicus | LYMPHOMAS | REVIEWS | LOCAL IRRADIATION | PATIENTS | EYES | CATARACTS | RADIOLOGY AND NUCLEAR MEDICINE | HOSPITALS | RADIOTHERAPY | GY RANGE 10-100 | MUCOUS MEMBRANES
Journal Article
Annals of Hematology, ISSN 0939-5555, 10/2018, Volume 97, Issue 10, pp. 1851 - 1857
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 06/2014, Volume 61, Issue 6, pp. 1104 - 1106
Patients <12 months with favorable biology, metastatic neuroblastoma have >90% overall survival following treatment with chemotherapy and surgery. We report... 
intermediate‐risk neuroblastoma | neuroblastoma | refractory disease | Intermediate-risk neuroblastoma | Refractory disease | Neuroblastoma | intermediate-risk neuroblastoma | CHROMOSOME 1P | CHEMOTHERAPY | CHILDREN | ONCOLOGY | TUMOR-CELL PLOIDY | TOPOTECAN | INFANTS | PEDIATRIC-ONCOLOGY-GROUP | PEDIATRICS | HEMATOLOGY | Adrenal Gland Neoplasms - surgery | Abdominal Neoplasms - secondary | Isotretinoin - therapeutic use | Prognosis | Humans | Salvage Therapy | Infant | Male | Risk | Antineoplastic Agents - therapeutic use | Biomarkers, Tumor | Neuroblastoma - secondary | Retroperitoneal Neoplasms - drug therapy | Retroperitoneal Neoplasms - genetics | Orbital Neoplasms - genetics | Female | Retroperitoneal Neoplasms - surgery | Abdominal Neoplasms - drug therapy | Neuroblastoma - genetics | Orbital Neoplasms - drug therapy | Treatment Outcome | Combined Modality Therapy | Lymphatic Metastasis | Abdominal Neoplasms - surgery | Disease Progression | Orbital Neoplasms - secondary | Thoracic Neoplasms - genetics | Thoracic Neoplasms - secondary | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neuroblastoma - drug therapy | Abdominal Neoplasms - genetics | Neuroblastoma - surgery | Watchful Waiting | Thoracic Neoplasms - drug therapy | Adrenal Gland Neoplasms - genetics | Development and progression | Care and treatment | Chemotherapy | Metastasis | Cancer | Index Medicus
Journal Article
Cancer Science, ISSN 1347-9032, 11/2011, Volume 102, Issue 11, pp. 1972 - 1976
We evaluated the association between tumor‐infiltrating FOXP3+ T cells and clinical outcomes in patients with ocular adnexal lymphoma of mucosa‐associated... 
HODGKINS LYMPHOMA | B-CELLS | SURVIVAL | HIGH NUMBERS | CHLAMYDIA-PSITTACI | ONCOLOGY | MARGINAL ZONE | REGULATORY T-CELLS | SJOGRENS-SYNDROME | FOLLICULAR LYMPHOMA | MALT LYMPHOMA | Lacrimal Apparatus Diseases - immunology | Conjunctival Neoplasms - drug therapy | Lymphoma, B-Cell, Marginal Zone - radiotherapy | Prognosis | Humans | Middle Aged | Eyelid Neoplasms - immunology | Male | Eye Neoplasms - immunology | Conjunctival Neoplasms - immunology | Antigens, CD - analysis | Antigens, Differentiation, T-Lymphocyte - analysis | Eye Neoplasms - drug therapy | Eyelid Neoplasms - radiotherapy | Lacrimal Apparatus Diseases - drug therapy | Female | Lymphocytes, Tumor-Infiltrating - chemistry | Lymphoma, B-Cell, Marginal Zone - pathology | Conjunctival Neoplasms - radiotherapy | Neoplasm Proteins - genetics | Republic of Korea - epidemiology | Orbital Neoplasms - radiotherapy | Caspases - genetics | Doxycycline - therapeutic use | Eye Neoplasms - pathology | Eyelid Neoplasms - drug therapy | Kaplan-Meier Estimate | Orbital Neoplasms - pathology | Lymphoma, B-Cell, Marginal Zone - immunology | Immunophenotyping | Orbital Neoplasms - drug therapy | Treatment Outcome | Eyelid Neoplasms - pathology | Conjunctival Neoplasms - pathology | Remission Induction | Lacrimal Apparatus Diseases - radiotherapy | Disease-Free Survival | Orbital Neoplasms - immunology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, B-Cell, Marginal Zone - drug therapy | Forkhead Transcription Factors - analysis | Watchful Waiting | Aged | Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein | Lacrimal Apparatus Diseases - pathology | Eye Neoplasms - radiotherapy | Lymphocytes, Tumor-Infiltrating - immunology | Evaluation | Care and treatment | Chemotherapy | Image processing | Oncology, Experimental | Monoclonal antibodies | Lymphomas | Equipment and supplies | Research | Drug therapy, Combination | T cells | Cancer | Index Medicus
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 04/2012, Volume 58, Issue 4, pp. 519 - 524
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 77, Issue 1, pp. 86 - 91
Purpose To evaluate the outcomes of patients with localized orbital marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma) who... 
Radiology | Hematology, Oncology and Palliative Medicine | Orbit | Marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) | Radiotherapy (RT) | AREA | ONCOLOGY | CATARACTS | OCULAR ADNEXA | CLASSIFICATION | CLINICAL BEHAVIOR | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Conjunctival Neoplasms - drug therapy | Cyclophosphamide - administration & dosage | Lymphoma, B-Cell, Marginal Zone - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Male | Young Adult | Eyelid Neoplasms - radiotherapy | Vincristine - administration & dosage | Adult | Female | Conjunctival Neoplasms - radiotherapy | Retrospective Studies | Orbital Neoplasms - radiotherapy | Doxorubicin - administration & dosage | Radiotherapy Dosage | Prednisone - administration & dosage | Cataract - etiology | Eyelid Neoplasms - drug therapy | Treatment Outcome | Radiation Injuries - complications | Remission Induction | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, B-Cell, Marginal Zone - drug therapy | Aged | Retreatment - methods | Lacrimal Duct Obstruction - etiology | Salvage Therapy - methods | Index Medicus | NEOPLASMS | IMMUNE SYSTEM DISEASES | MEMBRANES | RADIATION DOSES | MEDICINE | NUCLEAR MEDICINE | LYMPHOMAS | DISEASES | THERAPY | DOSES | RADIOLOGY AND NUCLEAR MEDICINE | RADIOLOGY | MUCOUS MEMBRANES
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2007, Volume 67, Issue 2, pp. 497 - 504
Purpose: Radiotherapy plays a major role in the treatment strategy of childhood sarcomas. Consequences of treatment are likely to affect the survivor’s quality... 
Radiology | Hematology, Oncology and Palliative Medicine | Irradiation | Sarcomas | Treatment | Proton therapy | Childhood | treatment | childhood | INTERGROUP RHABDOMYOSARCOMA | INTERNATIONAL-SOCIETY | irradiation | 2ND CANCERS | CHILDREN | MODULATED RADIATION-THERAPY | proton therapy | GROUP-III PATIENTS | ORBITAL RHABDOMYOSARCOMA | ONCOLOGY | X-RAY | RADIOTHERAPY | sarcomas | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PEDIATRIC-ONCOLOGY | Humans | Child, Preschool | Protons - therapeutic use | Infant | Male | Spinal Neoplasms - mortality | Spinal Neoplasms - drug therapy | Feasibility Studies | Meningeal Neoplasms - drug therapy | Sarcoma - mortality | Female | Child | Sarcoma - radiotherapy | Spinal Neoplasms - radiotherapy | Head and Neck Neoplasms - drug therapy | Survivors | Rhabdomyosarcoma, Embryonal - mortality | Rhabdomyosarcoma, Embryonal - drug therapy | Sarcoma - drug therapy | Meningeal Neoplasms - mortality | Head and Neck Neoplasms - radiotherapy | Adolescent | Quality of Life | Radiation Injuries - pathology | Meningeal Neoplasms - radiotherapy | Head and Neck Neoplasms - mortality | Rhabdomyosarcoma, Embryonal - radiotherapy | Care and treatment | Tumors | Index Medicus | HEAD | BONE MARROW | COBALT 50 | PROTON BEAMS | RADIATION DOSES | TOXICITY | HISTOLOGY | CHEMOTHERAPY | IRRADIATION | SARCOMAS | RADIOLOGY AND NUCLEAR MEDICINE | NECK | SIDE EFFECTS
Journal Article